Brief: Yichang Hec Changjiang Pharmaceutical Sees HY Profit Attributable Decrease By About 35%-45%
24/07/2020 15:13
July 24 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co
Ltd 1558.HK :
* SEES PROFIT ATTRIBUTABLE FOR HY DECREASE BY ABOUT 35%-45%
* EXPECTED RESULT DUE TO DECLINE IN SALES VOLUME OF DRUGS IN
HOSPITALS, AMONG OTHERS, IN H1 2020
Source text https://bit.ly/2OYPSY5
Further company coverage: 1558.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million